Late billionaire investor Rakesh Jhunjhunwala's firm Rare Enterprises-backed ConcordBiotech has filed its draft red herring prospectus (DRHP) with capital markets regulator Securities Exchange ...
Seamless reading experience. Save your favourite. Get updates on your preferred social platform Follow us for the latest news, insider access to events and more.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Some results have been hidden because they may be inaccessible to you